NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 255 filers reported holding NOVAVAX INC in Q3 2022. The put-call ratio across all filers is 1.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $76,692 | +7.2% | 10,322 | 0.0% | 0.00% | – |
| Q1 2023 | $71,531 | +5501.5% | 10,322 | -91.7% | 0.00% | -100.0% |
| Q4 2022 | $1,277 | -99.9% | 124,193 | +50.2% | 0.00% | 0.0% |
| Q3 2022 | $1,505,000 | -53.6% | 82,687 | +31.2% | 0.00% | -60.0% |
| Q2 2022 | $3,241,000 | -92.7% | 63,012 | -89.5% | 0.01% | -90.0% |
| Q1 2022 | $44,187,000 | -41.9% | 599,955 | +12.9% | 0.05% | -34.2% |
| Q4 2021 | $76,044,000 | -32.6% | 531,517 | -2.3% | 0.08% | -38.7% |
| Q3 2021 | $112,757,000 | – | 543,906 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,002,087 | $544,308,000 | 8.21% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 323,517 | $58,657,000 | 7.86% |
| Samsara BioCapital, LLC | 198,600 | $36,008,000 | 6.64% |
| Foresite Capital Management I, LLC | 66,810 | $12,113,000 | 6.11% |
| Foresite Capital Management II, LLC | 67,373 | $12,215,000 | 2.81% |
| SECTORAL ASSET MANAGEMENT INC | 191,200 | $34,666,000 | 2.63% |
| Rock Springs Capital Management LP | 461,000 | $83,584,000 | 1.82% |
| TSP Capital Management Group, LLC | 23,525 | $4,265,000 | 1.50% |
| Ikarian Capital, LLC | 195,700 | $35,483,000 | 1.19% |
| SevenOneSeven Capital Management | 1,744 | $316,000 | 1.16% |